43
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization

, ORCID Icon, &
Pages 3949-3966 | Received 16 Jan 2024, Accepted 12 Jun 2024, Published online: 19 Jun 2024